外体新型miRNA-126通过向非酒精性脂肪肝炎中的AhR-NLRP3通路来调解血管内皮功能障碍

Qiuhe Chen1, Lifeng Ye1, Liting Huang1

  • 1State Key Laboratory of Traditional Chinese Medicine Syndrome, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, 510006, Guangdong, China.

Scientific reports
|March 26, 2025
PubMed
概括

非酒精性脂肪肝炎 (NASH) 通过肝脏外体引起血管功能障碍. 外体miRNA-126激活NLRP3炎症体,导致NASH患者心血管风险.